Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proximal bile duct tumors

B W Kuvshinoff1, Y Fong, L H Blumgart

  • 1Department of Surgery, Division of Surgical Oncology, University of Missouri-Columbia, Columbia, Missouri, USA.

Surgical Oncology Clinics of North America
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of adjuvant therapy after liver resection for colorectal cancer metastases.

Clinical colorectal cancer·2002
Same author

Staging laparoscopy for potentially resectable noncolorectal, nonneuroendocrine liver metastases.

Annals of surgical oncology·2002
Same author

Peritoneal washings are not predictive of occult peritoneal disease in patients with hilar cholangiocarcinoma.

Journal of the American College of Surgeons·2002
Same author

Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes.

Journal of the American College of Surgeons·2001
Same author

Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.

Annals of surgery·2001
Same author

Results of hepatic resection for sarcoma metastatic to liver.

Annals of surgery·2001

Radiologic imaging aids in diagnosing bile duct cancer, predicting surgical success, and guiding palliative treatments for unresectable cases. Resection offers the only cure, with acceptable operative mortality and improved survival rates.

Area of Science:

  • Oncology
  • Radiology
  • Surgical Oncology

Background:

  • Bile duct cancer diagnosis and management remain challenging.
  • Identifying resectable cases is crucial for patient cure.
  • Palliative options are essential for unresectable disease.

Purpose of the Study:

  • To review modern radiologic diagnostic approaches for bile duct cancer.
  • To discuss the prediction of resectability and surgical outcomes.
  • To outline palliative management strategies for unresectable bile duct cancer.

Main Methods:

  • Review of current radiologic diagnostic techniques.
  • Analysis of surgical resection rates and outcomes.
  • Evaluation of palliative interventions including bypass, stenting, and radiotherapy.

Related Experiment Videos

Main Results:

  • Radiologic imaging accurately predicts resectability in 20-40% of patients.
  • Surgical resection offers the only chance for cure with acceptable operative mortality.
  • Median survival after resection is approximately 35 months.
  • Various palliative options exist for unresectable cases.

Conclusions:

  • Advanced imaging is key for bile duct cancer management.
  • Surgical resection provides the best chance for cure.
  • Palliative treatments significantly improve quality of life for unresectable patients.